Literature DB >> 1598938

Stability of midazolam hydrochloride in a flavored, dye-free oral solution.

S L Steedman1, J R Koonce, J E Wynn, N H Brahen.   

Abstract

The stability of injectable midazolam hydrochloride in a solution for oral use was studied at three temperatures over 56 days. A 2.5-mg/mL oral solution was prepared from injectable midazolam hydrochloride and a flavored, dye-free syrup. Samples of solution were stored in amber glass bottles at 7, 20, or 40 degrees C. Duplicate samples were analyzed by high-performance liquid chromatography on days 0, 1, 3, 5, 14, 21, 35, and 56. Samples were also visually inspected on each sampling day. The concentrations of all samples remained greater than 90% of the original concentration and there were no visual signs of microbial growth or changes in color, turbidity, or odor throughout the 56-day period. A 2.5-mg/mL solution of injectable midazolam in syrup was stable for 56 days at 7, 20, or 40 degrees C.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1598938

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  4 in total

1.  Stability of parenteral midazolam in an oral formulation.

Authors:  S E Walker; H A Grad; D A Haas; A Mayer
Journal:  Anesth Prog       Date:  1997

2.  A pilot study of the efficacy of oral midazolam for sedation in pediatric dental patients.

Authors:  D A Haas; S A Nenniger; R Yacobi; J G Magathan; H A Grad; P E Copp; M D Charendoff
Journal:  Anesth Prog       Date:  1996

3.  Stability of an oral midazolam solution for premedication in paediatric patients.

Authors:  D Soy; M C Lopez; L Salvador; L Parra; M Roca; E Chabas; C Codina; P Modamio; E L Mariño; J Ribas
Journal:  Pharm World Sci       Date:  1994-12-02

4.  Efficacy and Safety of Orally Administered Intravenous Midazolam Versus a Commercially Prepared Syrup.

Authors:  Katayoun Salem; Hossein Khoshrang; Maryam Kousha; Mahboobeh Hoseini; Marzieh Ranjbar; Shadi Baniasadi; Jamshid Salamzadeh
Journal:  Iran J Pediatr       Date:  2015-06-27       Impact factor: 0.364

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.